| Factor |
Telaprevir (n=46) |
Boceprevir (n=26) |
PEG/RBV (n=72) |
P |
| Age (years) |
51.2 (10.3) |
53.5 (9.4) |
50.3 (7.3) |
0.28 |
| Sex, n (%) |
|
|
|
0.38 |
| Female |
17 (37.0) |
13 (50.0) |
52(34.7) |
|
| Male |
29 (63.0) |
13 (50.0) |
47 (65.3) |
|
| Race, n (%) |
|
|
|
0.17 |
| Caucasian |
26 (68.4) |
12 (60.0) |
38 (54.3) |
|
| African-American |
6 (15.8) |
7 (35.0) |
24(34.3) |
|
| Hispanic |
0 (0.0) |
0 (0.0) |
3 (4.3) |
|
| Other |
6 (15.8) |
1 (5.0) |
5 (7.1) |
|
| Baseline BMI, kg/m2, mean (SD) |
29.7 (5.6) |
29.2 (4.2) |
29.0 (6.6) |
0.84 |
| Baseline weight, kg, mean (SD) |
88.4 (19.7) |
87.8 (16.6) |
94.4 (26.3) |
0.89 |
| Diabetes, n (SD) |
2(4.4) |
0(0.0) |
1(1.4) |
0.38 |
| Hypertension, n (SD) |
8 (17.8) |
3 (11.5) |
4 (5.6) |
0.11 |
Values presented as Mean (Standard Deviation with Analysis of variance)
Abbreviations: n=number of patients, SD=standard deviation |
